NO963805L - Cefalosporinderivater - Google Patents

Cefalosporinderivater

Info

Publication number
NO963805L
NO963805L NO963805A NO963805A NO963805L NO 963805 L NO963805 L NO 963805L NO 963805 A NO963805 A NO 963805A NO 963805 A NO963805 A NO 963805A NO 963805 L NO963805 L NO 963805L
Authority
NO
Norway
Prior art keywords
fluoro
lower alkyl
hydroxyphenyl
carboxy
substituted
Prior art date
Application number
NO963805A
Other languages
English (en)
Norwegian (no)
Other versions
NO963805D0 (no
Inventor
Paul Hebeisen
Ingrid Heinze-Krauss
Hans Richter
Valeri Runtz
Henri Stalder
Urs Weiss
George Petros Yiannikouros
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO963805D0 publication Critical patent/NO963805D0/no
Publication of NO963805L publication Critical patent/NO963805L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO963805A 1995-09-12 1996-09-11 Cefalosporinderivater NO963805L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95114303 1995-09-12
EP95114304 1995-09-12

Publications (2)

Publication Number Publication Date
NO963805D0 NO963805D0 (no) 1996-09-11
NO963805L true NO963805L (no) 1997-03-13

Family

ID=26138799

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963805A NO963805L (no) 1995-09-12 1996-09-11 Cefalosporinderivater

Country Status (15)

Country Link
US (1) US5804577A (zh)
JP (1) JPH09132578A (zh)
KR (1) KR100209839B1 (zh)
CN (1) CN1060778C (zh)
AU (1) AU709077B2 (zh)
CA (1) CA2184971A1 (zh)
CO (1) CO4750667A1 (zh)
CZ (1) CZ251896A3 (zh)
HU (1) HUP9602433A3 (zh)
IL (1) IL119215A0 (zh)
MA (1) MA23970A1 (zh)
NO (1) NO963805L (zh)
PL (1) PL316032A1 (zh)
SG (1) SG52841A1 (zh)
TR (1) TR199600715A2 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1173979C (zh) * 1998-06-22 2004-11-03 巴斯利尔药物股份公司 丙烯基头孢茵素衍生物
EP1006689B1 (en) * 1998-11-30 2008-02-06 Matsushita Electric Industries Co., Ltd. Packet retransmission control using priority information
ATE308549T1 (de) * 2000-08-14 2005-11-15 Basilea Pharmaceutica Ag Herstellung von n-geschützten-3-pyrrolidin-lactam substituierten phosphonium salzen
KR101128065B1 (ko) * 2004-05-26 2012-04-12 에자이 알앤드디 매니지먼트 가부시키가이샤 신나미드 화합물
EP1808432B1 (en) 2004-10-26 2010-02-24 Eisai R&D Management Co., Ltd. Amorphous form of cinnamide compound
EP1950211A4 (en) * 2005-11-18 2011-08-31 Eisai R&D Man Co Ltd PROCESS FOR PREPARING A CINEMA ACID AMID DERIVATIVE
WO2007058304A1 (ja) * 2005-11-18 2007-05-24 Eisai R & D Management Co., Ltd. シンナミド化合物の塩またはそれらの溶媒和物
TWI378091B (en) * 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
JPWO2007135970A1 (ja) * 2006-05-19 2009-10-01 エーザイ・アール・アンド・ディー・マネジメント株式会社 ヘテロ環系−シンナミド誘導体
JPWO2007135969A1 (ja) * 2006-05-19 2009-10-01 エーザイ・アール・アンド・ディー・マネジメント株式会社 ウレア系−シンナミド誘導体
US20080207900A1 (en) * 2007-02-28 2008-08-28 Teiji Kimura Two cyclic oxomorphorin derivatives
JPWO2008140111A1 (ja) * 2007-05-16 2010-08-05 エーザイ・アール・アンド・ディー・マネジメント株式会社 シンナミド誘導体のワンポット製造方法
MX2010002098A (es) * 2007-08-31 2010-03-30 Eisai R&D Man Co Ltd Compuesto policiclico.
US7935815B2 (en) * 2007-08-31 2011-05-03 Eisai R&D Management Co., Ltd. Imidazoyl pyridine compounds and salts thereof
WO2009096349A1 (ja) * 2008-01-28 2009-08-06 Eisai R & D Management Co., Ltd. 結晶性のシンナミド化合物またはその塩

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255423A (en) * 1977-07-27 1981-03-10 Merck & Co., Inc. Cephalosporin compounds
GB8821797D0 (en) * 1988-09-16 1988-10-19 Beecham Group Plc Novel compounds
EP0620225B1 (en) * 1993-04-16 2002-11-13 Basilea Pharmaceutica AG Cephalosporin derivatives
US5523400A (en) * 1993-04-16 1996-06-04 Hoffmann-La Roche Inc. Cephalosporin antibiotics

Also Published As

Publication number Publication date
IL119215A0 (en) 1996-12-05
CO4750667A1 (es) 1999-03-31
AU6550696A (en) 1997-03-20
SG52841A1 (en) 1998-09-28
AU709077B2 (en) 1999-08-19
CA2184971A1 (en) 1997-03-13
HUP9602433A2 (en) 1997-05-28
CN1150950A (zh) 1997-06-04
NO963805D0 (no) 1996-09-11
PL316032A1 (en) 1997-03-17
JPH09132578A (ja) 1997-05-20
US5804577A (en) 1998-09-08
KR100209839B1 (ko) 1999-07-15
KR970015593A (ko) 1997-04-28
CZ251896A3 (en) 1997-04-16
TR199600715A2 (tr) 1997-03-21
MA23970A1 (fr) 1997-04-01
MX9604017A (es) 1997-07-31
CN1060778C (zh) 2001-01-17
HU9602433D0 (en) 1996-10-28
HUP9602433A3 (en) 2001-04-28

Similar Documents

Publication Publication Date Title
NO963805L (no) Cefalosporinderivater
EP1505068A4 (en) PYRAZOLO (1,5-a) PYRIMIDINE DERIVATIVE AND INHIBITOR OF NAD (P) H OXIDASE CONTAINING SAID DERIVATIVE
IN2015DN01133A (zh)
NO20013369L (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
CA2296031A1 (en) Novel spiroazabicyclic heterocyclic compounds
CA2139109A1 (en) Purinone Antianginal Agents
NO20062136L (no) Imidazopyrazintyrosin-kinaseinhibitorer
TNSN05320A1 (en) Pyrido` 2, 1-a - isoquinoline derivatives as dpp-iv inhibitors
EP1199306A4 (en) Biaryl UREA DERIVATIVES
AU3821889A (en) 4-oxoquinoline-3-carboxylic acid derivatives, their preparation and their use
EP0725074A3 (en) Compounds for use, therefore, intermediates for the preparation of androst-3,5-diene-3-carboxy derivatives
CA2208792A1 (en) Substituted indazole derivatives
SE9701304D0 (sv) Compounds
IE890177L (en) Piperidinyl derivatives
HRP940287B1 (en) Substituted pyrroles
AU2001292350A1 (en) Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
CA2073633A1 (en) Use of xanthine derivatives for the treatment of secondary nerve cell damage and functional disorders after cranio-cerebral traumas
PT1303514E (pt) Processo para preparacao de azacicloalcanoilaminotiazoles
EP1034783A4 (en) AMIDE DERIVATIVES
AU4558800A (en) Synergistic combination comprising roflumilast and a pde-3 inhibitor
HUT75649A (en) Optically active imidazolidinone derivative and pharmaceutical compositions containing them
PT90261A (pt) Processo para a preparacao de novos derivados com a estrutura do 3-(1-fenil-2-propenil)-{2h}-cromeno
NO993372L (no) Substituerte 4-(6-fluor-(1H)-indol-3-yl)-1,2,3,6-tetrahydropyridin for behandling av CNS-forstyrrelser
AU538882B2 (en) 2,3-dihydro-imidazo(1,2-g)pyridazine derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application